Prof. Hu is the Vice Dean of Zhejiang University School of Medicine, a Qiushi Distinguished Professor, Director Physician, and Doctoral Supervisor. As a leading physician-scientist in hematology, she specializes in the treatment of hematologic malignancies, with a dedicated focus on bone marrow transplantation and cellular immunotherapy, particularly CAR-T cell therapy. Her groundbreaking translational research bridges advanced laboratory science with clinical practice to improve outcomes for patients. Prof. Hu is the recipient of the prestigious 2024 National Science Fund for Distinguished Young Scholars. She has authored over 50 high-impact publications as first or corresponding author in top-tier journals including the New England Journal of Medicine, Nature, and The Lancet Haematology.

CAR-T Cell Immunotherapy for Lymphomas, Leukemias, Multiple Myeloma or Autoimmune disease

CAR-T Therapy Bridged to Allogeneic or Autologous Hematopoietic Stem Cell Transplantation

Management of complications post-transplantation and cellular therapy

Recipient, National Science Fund for Distinguished Young Scholars (2024)

Zhejiang Province High-Level Innovative Health Talent

Second Awardee, Zhejiang Province Science and Technology Progress Award

Principal Investigator of 6 national and ministerial-level research projects

Member, Lymphocyte Diseases Group, Hematology Society, Chinese Medical Association

Member, Hematologic Oncology Committee, Chinese Anti-Cancer Association

Standing Committee Member, Cell Research and Therapy Committee, Chinese Research Hospital Association

Vice Chairperson, Transplantation and Immunotherapy Group, Blood Physiology Committee, Chinese Physiological Society

Member, Experimental Hematology Committee, Chinese Society of Pathophysiology